SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-07-016389
Filing Date
2007-08-14
Accepted
2007-08-14 16:30:21
Documents
1
Period of Report
2007-08-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4852
  Complete submission text file 0001140361-07-016389.txt   6970
Mailing Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131
Business Address 1101 BRICKELL AVENUE SUITE 701 S MIAMI FL 33131 305-534-3383
DOR BIOPHARMA INC (Issuer) CIK: 0000812796 (see all company filings)

IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 509 MADISON AVE 14TH FL NEW YORK NY 10022
Business Address DISCOVERY LABORATORIES INC 509 MADISON AVE 14TH FLOOR NEW YORK NY 10022 2122234504
MYRIANTHOPOULOS EVAN (Reporting) CIK: 0001050955 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-16929 | Film No.: 071055703